Innoviva (INVA)
Funds hospital critical-care and infectious-disease drugs with GSK respiratory royalties.
$20.99
vs last close+0.01 (+0.05%)
Something off on this page? Send us feedback.
Next report
Nov 4, 26
in 42 days
EPS estimate
$0.50
Revenue estimate
$115.4M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$0.26$0.74$0.77$1.08$1.94$0.44$1.14Pending
Estimate$0.34$0.29$0.57$0.46$0.34$0.43$0.44$0.50
Surprise−23.5%+151.9%+35.1%+134.8%+470.6%+2.3%+161.5%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$91.8M$88.6M$100.3M$107.8M$114.6M$98.0M$119.6MPending
Estimate$86.8M$82.7M$92.0M$91.4M$102.6M$101.6M$111.0M$115.4M
Surprise+5.8%+7.2%+9.0%+18.0%+11.7%−3.5%+7.8%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $0.63 | — | — |
| Sep 2027 | $0.61 | — | — |
| Jun 2027 | $0.59 | — | — |
| Mar 2027 | $0.52 | — | — |
| Dec 2026 | $0.53 | — | — |
| Nov 2026 | $0.50 | — | — |
| Aug 2026 | $0.44 | $1.14 | +161.5% |
| May 2026 | $0.43 | $0.44 | +2.3% |
| Feb 2026 | $0.34 | $1.94 | +470.6% |
| Nov 2025 | $0.46 | $1.08 | +134.8% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Jul 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| Apr 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Jul 2022 | |||
| Apr 2022 | |||
| Feb 2022 | |||
| Oct 2021 | |||
| Jul 2021 | |||
| Apr 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Feb 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Oct 2018 | |||
| Jul 2018 | |||
| Apr 2018 | |||
| Feb 2018 | |||
| Oct 2017 | |||
| Jul 2017 | |||
| Apr 2017 | |||
| Feb 2017 | |||
| Oct 2016 | |||
| Jul 2016 | |||
| Apr 2016 | |||
| Feb 2016 | |||
| Oct 2015 | |||
| Jul 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $0.63 | — | — | $128.5M | — | — | — |
| Sep 2027 | $0.61 | — | — | $125.2M | — | — | — |
| Jun 2027 | $0.59 | — | — | $122.1M | — | — | — |
| Mar 2027 | $0.52 | — | — | $114.9M | — | — | — |
| Dec 2026 | $0.53 | — | — | $118.2M | — | — | — |
| Nov 4, 2026 | $0.50 | — | — | $115.4M | — | — | — |
| Aug 5, 2026 | $0.44 | $1.14 | +161.5% | $111.0M | $119.6M | +7.8% | +2.9% |
| May 6, 2026 | $0.43 | $0.44 | +2.3% | $101.6M | $98.0M | −3.5% | −0.6% |
| Feb 25, 2026 | $0.34 | $1.94 | +470.6% | $102.6M | $114.6M | +11.7% | −2.9% |
| Nov 5, 2025 | $0.46 | $1.08 | +134.8% | $91.4M | $107.8M | +18.0% | +0.4% |
| Aug 6, 2025 | |||||||
| May 7, 2025 | |||||||
| Feb 26, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Jul 31, 2024 | |||||||
| May 8, 2024 | |||||||
| Mar 1, 2024 | |||||||
| Nov 1, 2023 | |||||||
| Aug 2, 2023 | |||||||
| Apr 26, 2023 | |||||||
| Feb 28, 2023 | |||||||
| Nov 9, 2022 | |||||||
| Jul 27, 2022 | |||||||
| Apr 27, 2022 | |||||||
| Feb 9, 2022 | |||||||
| Oct 27, 2021 | |||||||
| Jul 28, 2021 | |||||||
| Apr 28, 2021 | |||||||
| Feb 3, 2021 | |||||||
| Oct 28, 2020 | |||||||
| Jul 29, 2020 | |||||||
| Apr 29, 2020 | |||||||
| Feb 5, 2020 | |||||||
| Oct 30, 2019 | |||||||
| Jul 24, 2019 | |||||||
| May 1, 2019 | |||||||
| Feb 6, 2019 | |||||||
| Oct 31, 2018 | |||||||
| Jul 26, 2018 | |||||||
| Apr 26, 2018 | |||||||
| Feb 8, 2018 | |||||||
| Oct 25, 2017 | |||||||
| Jul 26, 2017 | |||||||
| Apr 27, 2017 | |||||||
| Feb 9, 2017 | |||||||
| Oct 27, 2016 | |||||||
| Jul 28, 2016 | |||||||
| Apr 28, 2016 | |||||||
| Feb 3, 2016 | |||||||
| Oct 28, 2015 | |||||||
| Jul 29, 2015 |